Merck Wards Off More Januvia Infringers In India
This article was originally published in PharmAsia News
Executive Summary
Merck & Co has moved to fend off a clutch of smaller Indian players that allegedly contract manufacture and export two of its diabetes therapies, or hope to introduce copies of these on the domestic market, infringing on its patents.